Morgan Stanley’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.85M | Buy |
|
|||||
|
2025
Q1 | $5.84M | Buy |
|
|||||
|
2024
Q4 | $9.14M | Buy |
|
|||||
|
2024
Q3 | $6.2M | Sell |
|
|||||
|
2024
Q2 | $19.4M | Sell |
|
|||||
|
2024
Q1 | $29.3M | Sell |
|
|||||
|
2023
Q4 | $36.7M | Buy |
|
|||||
|
2023
Q3 | $14.7M | Buy |
|
|||||
|
2023
Q2 | $5.98M | Buy |
|
|||||
|
2023
Q1 | $2.82M | Sell |
|
|||||
|
2022
Q4 | $2.05M | Buy |
|
|||||
|
2022
Q3 | $1.25M | Sell |
|
|||||
|
2022
Q2 | $4.91M | Buy |
|
|||||
|
2022
Q1 | $7.55M | Buy |
|
|||||
|
2021
Q4 | $5.09M | Buy |
|
|||||
|
2021
Q3 | $6.57M | Sell |
|
|||||
|
2021
Q2 | $8.38M | Buy |
|
|||||
|
2021
Q1 | $3.66M | Buy |
|
|||||
|
2020
Q4 | $1.76M | Buy |
|
|||||
|
2020
Q3 | $1.43M | Sell |
|
|||||
|
2020
Q2 | $7.12M | Sell |
|
|||||
|
2020
Q1 | $2.75M | Buy |
|
|||||
|
2019
Q4 | $1.73M | Buy |
|
|||||
|
2019
Q3 | $812K | Buy |
|
|||||
|
2019
Q2 | $408K | Sell |
|
|||||
|
2019
Q1 | $479K | Sell |
|
|||||
|
2018
Q4 | $324K | Buy |
|
|||||
|
2018
Q3 | $424K | Sell |
|
|||||
|
2018
Q2 | $448K | Buy |
|
|||||
|
2018
Q1 | $214K | Buy |
|
|||||
|
2017
Q4 | $271K | Sell |
|
|||||
|
2017
Q3 | $259K | Buy |
|
|||||
|
2017
Q2 | $249K | Sell |
|
|||||
|
2017
Q1 | $539K | Buy |
|
|||||
|
2016
Q4 | $29K | Sell |
|
|||||
|
2016
Q3 | $48K | Sell |
|
|||||
|
2016
Q2 | $96K | Sell |
|
|||||
|
2016
Q1 | $85K | Sell |
|
|||||
|
2015
Q4 | $173K | Sell |
|
|||||
|
2015
Q3 | $258K | Sell |
|
|||||
|
2015
Q2 | $282K | Sell |
|
|||||
|
2015
Q1 | $251K | Buy |
|
|||||
|
2014
Q4 | $114K | Sell |
|
|||||
|
2014
Q3 | $1.79M | Buy |
|
|||||
|
2014
Q2 | $1.69M | Buy |
|
|||||
|
2014
Q1 | $580K | Buy |
|
|||||
|
2013
Q4 | $92K | Buy |
|